Russell Skibsted, Chief Financial Officer at Processa Pharmaceuticals, Inc. (PCSA), bought 3,277 shares at $1.93 ($6K) on 2026-06-30, disclosed to the SEC on 2026-07-01.
Open-market purchase of $6k PCSA by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| PCSA | BUY | 2026-05-19 | $6K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $6K | — | Filing → |
| PCSA | BUY | 2026-04-17 | $6K | — | Filing → |